Ignite Creation Date:
2024-05-05 @ 9:57 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002175
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
Epicutaneous 1-Chloro-2 4-Dinitrobenzene DNCB Patch in HIV Infection
Sponsor:
The Honolulu Medical Group
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
Epicutaneous 1-Chloro-2 4-Dinitrobenzene DNCB Patch in HIV Infection
Status:
COMPLETED
Status Verified Date:
1999-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the efficacy of dinitrochlorobenzene DNCB in patients with early HIV infection by monitoring immunologic parameters and serum HIV RNA To facilitate the understanding of possible alterations in the immunological status of the HIV patient cohort
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: